Literature DB >> 12436832

Inhalational and enteral conscious sedation for the adult dental patient.

Douglass L Jackson1, Barton S Johnson.   

Abstract

There are clearly many safe and effective sedatives available to the dental practitioner for reducing patient fear and improving their level of comfort. Careful consideration needs to be given to the objectives of the sedation when deciding which pharmacologic agents to use because they all possess slightly different clinical characteristics and various degrees of risk. Patient selection also is critical when making decisions about sedation because the patient's expectations and general health status factor into keeping the procedure safe. N2O/O2 sedation is an excellent choice for managing the mildly fearful dental patient or when minimal sedation is desirable. Among the sedatives administered enterally, the benzodiazepines are the most commonly used, and for good reason. These drugs are safe, effective, and offer a host of different personalities from which the dentist can choose. If used wisely and thoughtfully, the dentist can tailor the effects and duration of onset and recovery to the needs of the patient and the expected parameters of the appointment. When N2O/O2 sedation is combined with a single enteral sedative, a more profound level of CNS depression is achieved that can be modestly altered by changing the concentration of inhaled nitrous oxide. With these many pharmacologic alternatives, many different dental patient populations can be sedated in a safe, effective manner, thus allowing the delivery of most dental treatments in a setting of reduced psychologic and physiologic stress. These pharmacologic sedatives have truly opened up a wonderful world of possibilities for the comfortable delivery of dental care, and should be integrated into every office's repertoire for delivery of care.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12436832     DOI: 10.1016/s0011-8532(02)00029-0

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  5 in total

1.  Nitrous oxide-induced NO-dependent neuronal release of β-endorphin from the rat arcuate nucleus and periaqueductal gray.

Authors:  Yusuke Ohgami; Eunhee Chung; Raymond M Quock
Journal:  Brain Res       Date:  2010-11-06       Impact factor: 3.252

Review 2.  Advances in understanding the actions of nitrous oxide.

Authors:  Dimitris E Emmanouil; Raymond M Quock
Journal:  Anesth Prog       Date:  2007

3.  Expanded studies of the pharmacokinetics and clinical effects of multidose sublingual triazolam in healthy volunteers.

Authors:  Jacqueline E Pickrell; Kazuo Hosaka; Douglass L Jackson; Masahiro Heima; Evan Kharasch; Peter M Milgrom
Journal:  J Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.153

4.  Flumazenil reversal of sublingual triazolam: a randomized controlled clinical trial.

Authors:  Kazuo Hosaka; Douglass Jackson; Jacqueline E Pickrell; Masahiro Heima; Peter Milgrom
Journal:  J Am Dent Assoc       Date:  2009-05       Impact factor: 3.634

5.  Use of triazolam and alprazolam as premedication for general anesthesia.

Authors:  Doyun Kim; Seongheon Lee; Taehee Pyeon; Seongwook Jeong
Journal:  Korean J Anesthesiol       Date:  2015-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.